
Satya Marar
-
Visiting Postgraduate Fellow
Satya Marar is a Visiting Postgraduate Fellow at the Mercatus Center at George Mason University where he was formerly an MA Fellow. He holds an MA in Economics from George Mason University and a BA in writing and an LLB with Honors in law from Macquarie University in Sydney, Australia. He is currently pursuing an LLM in US law at George Mason University. He has previously worked at Reason Foundation and the Australian Taxpayers’ Alliance. His research interests include antitrust & competition policy, intellectual property, trade and technology policy.
Latest Work
- | Antitrust and Competition Antitrust and Competition
- | Amicus Briefs Amicus Briefs
Federal Circuit Case: In re SAP America, Inc.
Amicus brief in support of the USPTO’s discretion to deny IPR petitions and against SAP America, Inc.’s mandamus request
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Mergers Are Back on the Menu | Competition Corner (Substack)
- | Antitrust and Competition Antitrust and Competition
- | Public Interest Comments Public Interest Comments
Omnicom Group Inc. (‘‘Omnicom’’) and the Interpublic Group of Companies, Inc. (‘‘IPG’’); Analysis of Agreement Containing Consent Order to Aid Public Comment
Comment urges FTC to clarify that the Order targets only joint, collusive behavior and not unilateral decisions by Omnicom
- | Antitrust and Competition Antitrust and Competition
- | Radio Appearance Radio Appearance
Why Are Medicine Prices So High in America? | The Brian Nichols Show
- | Antitrust and Competition Antitrust and Competition
- | Public Interest Comments Public Interest Comments
The Federal Trade Commission’s and the U.S. Department of Justice’s Request for Information on Harmful Practices and on Potential Regulation or Legislation to Protect Consumers in the Concert and Entertainment Industry
Comment urges the FTC and DOJ to target specific anticompetitive conduct and adopt consumer-focused rules instead of structural breakups
- | Antitrust and Competition Antitrust and Competition
- | Podcast Appearance Podcast Appearance
Trump’s Attempt To Cure Drug Prices Is a Wrong Step in the Right Direction | Moving Forward with Young Voices
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Race to the Bottom | Competition Corner (Substack)
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Trump’s Attempt to Curb Drug Prices Is a Wrong Step in the Right Direction | DC Journal and InsideSources
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
AI and the Future of Competition | Competition Corner (Substack)
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
The FTC: Free Speech Champion? | Competition Corner (Substack)
- | Antitrust and Competition Antitrust and Competition
- | Amicus Briefs Amicus Briefs
Federal Circuit Case: In re SAP America, Inc.
Amicus brief in support of the USPTO’s discretion to deny IPR petitions and against SAP America, Inc.’s mandamus request
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Mergers Are Back on the Menu | Competition Corner (Substack)
- | Antitrust and Competition Antitrust and Competition
- | Public Interest Comments Public Interest Comments
Omnicom Group Inc. (‘‘Omnicom’’) and the Interpublic Group of Companies, Inc. (‘‘IPG’’); Analysis of Agreement Containing Consent Order to Aid Public Comment
Comment urges FTC to clarify that the Order targets only joint, collusive behavior and not unilateral decisions by Omnicom
- | Antitrust and Competition Antitrust and Competition
- | Radio Appearance Radio Appearance
Why Are Medicine Prices So High in America? | The Brian Nichols Show
- | Antitrust and Competition Antitrust and Competition
- | Public Interest Comments Public Interest Comments
The Federal Trade Commission’s and the U.S. Department of Justice’s Request for Information on Harmful Practices and on Potential Regulation or Legislation to Protect Consumers in the Concert and Entertainment Industry
Comment urges the FTC and DOJ to target specific anticompetitive conduct and adopt consumer-focused rules instead of structural breakups
- | Antitrust and Competition Antitrust and Competition
- | Podcast Appearance Podcast Appearance
Trump’s Attempt To Cure Drug Prices Is a Wrong Step in the Right Direction | Moving Forward with Young Voices
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Race to the Bottom | Competition Corner (Substack)
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Trump’s Attempt to Curb Drug Prices Is a Wrong Step in the Right Direction | DC Journal and InsideSources
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
AI and the Future of Competition | Competition Corner (Substack)
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
The FTC: Free Speech Champion? | Competition Corner (Substack)
- | Antitrust and Competition Antitrust and Competition
- | Working Papers Working Papers
Is Data Really a Barrier to Entry? Rethinking Competition Regulation in Generative AI
Fears of data scarcity and monopolization are unfounded and risk leading to overregulation.
- | Antitrust and Competition Antitrust and Competition
- | Research Papers Research Papers
Artificial Intelligence and Antitrust Law: A Primer
- | Antitrust and Competition Antitrust and Competition
- | Policy Briefs Policy Briefs
Unintended Consequences: The Real Effects of Populist Antitrust Policies on Competition and Small Enterprises
- | Antitrust and Competition Antitrust and Competition
- | Policy Briefs Policy Briefs
Proceedings of the 2024 Annual Mercatus Center Antitrust Forum
- | Antitrust and Competition Antitrust and Competition
- | Policy Briefs Policy Briefs
Antitrust Enforcement in 2023: Year in Review for the Federal Trade Commission and the Department of Justice
- | Antitrust and Competition Antitrust and Competition
- | Policy Briefs Policy Briefs
The Robinson-Patman Act: A Statute at Odds with Competition and Economic Welfare
- | Antitrust and Competition Antitrust and Competition
- | Radio Appearance Radio Appearance
Why Are Medicine Prices So High in America? | The Brian Nichols Show
- | Antitrust and Competition Antitrust and Competition
- | Podcast Appearance Podcast Appearance
Trump’s Attempt To Cure Drug Prices Is a Wrong Step in the Right Direction | Moving Forward with Young Voices
- | Antitrust and Competition Antitrust and Competition
- | Radio Appearance Radio Appearance
The Drug Act Could Backfire by Raising Costs for Patients and Taxpayers | The Jeff Kennedy Show
- | Antitrust and Competition Antitrust and Competition
- | Podcast Appearance Podcast Appearance
The Pandemic's Effect on Schools and School Choice | The Chris Spangle Show
- | Antitrust and Competition Antitrust and Competition
- | Public Interest Comments Public Interest Comments
Omnicom Group Inc. (‘‘Omnicom’’) and the Interpublic Group of Companies, Inc. (‘‘IPG’’); Analysis of Agreement Containing Consent Order to Aid Public Comment
Comment urges FTC to clarify that the Order targets only joint, collusive behavior and not unilateral decisions by Omnicom
- | Antitrust and Competition Antitrust and Competition
- | Public Interest Comments Public Interest Comments
The Federal Trade Commission’s and the U.S. Department of Justice’s Request for Information on Harmful Practices and on Potential Regulation or Legislation to Protect Consumers in the Concert and Entertainment Industry
Comment urges the FTC and DOJ to target specific anticompetitive conduct and adopt consumer-focused rules instead of structural breakups
- | Antitrust and Competition Antitrust and Competition
- | Public Interest Comments Public Interest Comments
The European Commission's Draft "Proposal for a Regulation of the European Parliament and of the Council on Standard Essential Patents" is Unnecessary and Harmful
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Mergers Are Back on the Menu | Competition Corner (Substack)
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Race to the Bottom | Competition Corner (Substack)
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Trump’s Attempt to Curb Drug Prices Is a Wrong Step in the Right Direction | DC Journal and InsideSources
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
AI and the Future of Competition | Competition Corner (Substack)
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
The FTC: Free Speech Champion? | Competition Corner (Substack)
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Curbing Competition Won’t Lower Drug Prices | CounterPunch
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
“America First Antitrust” and a Conversation With Prof. John M. Yun | Competition Corner (Substack)
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Some Breakups Are More Painful Than Others | Competition Corner
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Humphrey Gets Executed? | Competition Corner (Substack)
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary